US Stock Reports, Quotes and News
Infosys (NS:INFY) announced a robust performance for Q4 FY24, with a net profit of INR 7,975 crore, marking a significant 30% YoY increase. Despite challenges, the company reported a 1.3% YoY growth in revenue, reaching INR 37,923 crore.
Goldman Sachs (GS) has delivered strong first-quarter results for 2024, with net revenues reaching $14.2 billion and net earnings of $4.1 billion. The company\’s Global Banking & Markets segment was a significant contributor, generating $9.7 billion in revenues, thanks to notable performances in advisory, equity underwriting, and debt underwriting.
Investing.com– Chinese stocks saw a strong recovery in the first quarter of 2024 amid some improvements in the economy and earnings, Goldman Sachs analysts said in a recent note.
In their first-quarter European earnings preview, analysts at Goldman Sachs said in a note that better macro momentum will support earnings releases this quarter.
Investing.com – Goldman Sachs (NYSE: GS) reported first quarter EPS of $11.58, $2.84 better than the analyst estimate of $8.74. Revenue for the quarter came in at $14.21B versus the consensus estimate of $12.94B.
(Reuters) – Goldman Sachs profit rose 28% in the first quarter, buoyed by a recovery in debt underwriting and dealmaking that boosted its investment banking unit, it reported on Monday.
Goldman Sachs profit rose 28% in the first quarter, buoyed by a recovery in debt underwriting and dealmaking that boosted its investment banking unit, it reported on Monday.
Goldman Sachs has expanded its coverage to the India CRO/CDMO (contract research organization/contract development and manufacturing organization) space as supply diversification in the global pharmaceutical industry picks up. In a note, analysts initiated coverage on three stocks – two Buys and one Sell.
Global broking firm Goldman Sachs on Friday initiated coverage on Syngene International and Neuland Labs with buy ratings but gave a sell call on Laurus Labs.